Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Clinical trial NCT00072566 · COMPLETED

Trial details

NCT number: NCT00072566
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Peritoneal Carcinoma Recurrent Ovarian Carcinoma Stage IV Ovarian Cancer

Start date: 2003-12-01
Primary completion: 2008-11-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.